Rapid Micro Biosystems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rapid Micro Biosystems generated cash of -$45,081,000, which is more than the previous year. Cash used in financing activities reached the amount of $149,000 last year. Net change in cash is therefore -$2,779,000.
Cash Flow
| 2019 | -21.14M | -1.69M | 14.87M |
|---|---|---|---|
| 2020 | -30.99M | -15.67M | 64.23M |
| 2021 | -54.96M | -13.28M | 216.74M |
| 2022 | -58.54M | -93.46M | 693K |
| 2023 | -45.08M | 42.15M | 149K |
RPID Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 27.34M | 178.67M | 30.17M | 12.61M | 20.58M |
Operating activities | |||||
Net income | -52.46M | -60.80M | -73.52M | -37.07M | -21.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.10M | 2.83M | 1.52M | 1.50M | 1.46M |
Stock-based compensation expense | 4.75M | 4.01M | 1.84M | 533K | 473K |
| Deferred income tax benefit | 4.75M | 4.01M | 1.84M | 533K | 473K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -163K | -364K | -17K | -1.36M | -511K |
Inventories | 1.19M | -5.84M | -6.76M | -3.36M | -3.92M |
Accounts payable | -3.45M | 1.48M | -524K | 978K | 1.03M |
Cash generated by operating activities | -45.08M | -58.54M | -54.96M | -30.99M | -21.14M |
Investing activities | |||||
Purchases Of Investments | -62.49M | -179.22M | -25.09M | -24.98M | 0 |
Investments In Property Plant And Equipment | -1.84M | -6.74M | -3.21M | -690K | -1.69M |
Acquisitions Net | 0 | 86.72M | 20K | 14.98M | 0 |
Cash generated by investing activities | 42.15M | -93.46M | -13.28M | -15.67M | -1.69M |
Financing activities | |||||
Common Stock Issued | 186K | 726K | 164.11M | 72K | 11K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 180K | 160K | 0 | 0 | 0 |
Repayments of term debt | -37K | -33K | -26.17M | -18M | 0 |
Cash used in financing activities | 149K | 693K | 216.74M | 64.23M | 14.87M |
Net Change In Cash | -2.77M | -151.32M | 148.49M | 17.56M | -7.97M |
Cash at end of period | 24.56M | 27.34M | 178.67M | 30.17M | 12.61M |
| Data source | Data source | Data source |